Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05251246
Other study ID # 69HCL21_0774
Secondary ID 2021-A02218-33
Status Recruiting
Phase N/A
First received
Last updated
Start date February 8, 2022
Est. completion date February 2023

Study information

Verified date February 2022
Source Hospices Civils de Lyon
Contact Marion DOUPLAT, MD
Phone 06 15 34 80 33
Email marion.douplat@chu-lyon.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The investigators hypothesize that a recovery management program could have an impact on emergency nurses and physicians by improving their sleep and reducing their psychological and physiological responses when dealing with stressful situations during their professional practice. The REST study consists in developing a recovery management program for emergency professionals. The following strategies would be proposed : - sleep management according to their schedules by anticipation and recovery, - stress management through cardio-feedback techniques (cardiac coherence) also called controlled breathing techniques and mental imagery. The objectives are to evaluate the impact of this program on the physiological and psychological stress of the emergency professionals during their professional activity, as well as on their sleep. To do so, their respiratory and heart rates, as well as their activity and resting times will be recorded continuously for one week. At the end of each shift, the emergency professionals will report and evaluate the 3 most stressful events.


Recruitment information / eligibility

Status Recruiting
Enrollment 62
Est. completion date February 2023
Est. primary completion date January 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Nurses or physicians - In current position for at least one year - Full time or minimum three shifts per week - Location: Emergency Department of the Edouard Herriot Hospital or the South Lyon Hospital - Free and informed consent Exclusion Criteria: - Caregivers on leave during the enrollment period - Pregnant, parturient or breastfeeding caregivers - Participation in another study

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
recovery management program
The recovery management program consists in training the nurses and physicians during a 15-day training course to optimize their recovery abilities : sleep management according to the schedules by anticipation and recovery, and stress management through cardio-feedback techniques (cardiac coherence) also called controlled breathing techniques and mental imagery.

Locations

Country Name City State
France Hôpital Lyon Sud Pierre-Bénite

Sponsors (2)

Lead Sponsor Collaborator
Hospices Civils de Lyon Institut National de la Santé Et de la Recherche Médicale, France

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Comparison of the recovery capacity for self-reported stressful events after the recovery management program During the 30 minutes following self-reported stressful events, the physiological responses to stress (heart rate) are compared between the trained and non-trained emergency professionals. 30 minutes post-stressful events
Secondary Evaluation of the perceived stress of the emergency professionals across one week of shift work before and after implementation of the recovery management program. After each monitored week of shift work, the overall perceived stress is collected once using the Perceived Stress Scale (PSS ranging from 0 minimum to 42 maximum). 2 days (Day22 & Day51)
Secondary Evaluation of the perceived stress of the emergency professionals during the shift work before and after implementation of the recovery management program Before (baseline) and after each shift, the perceived stress during the experienced shift is collected every time using the Visual Analogue Scale VAS for stress intensity (VAS-Stress ranging from 0 minimum to 10 maximum). 6 days (each shift between Day 15 - Day 21 & Day 44-51)
Secondary Evaluation of the psychological markers of stress for self-reported stressful events before and after implementation of the recovery management program. After the shift following self-reported stressful events, the psychological markers of stress are evaluated using the visual analogue scale (VAS-event ranging from 0 minimum to 10 maximum) to indicate the intensity of each event. 6 days (between Day 15- Day 21 & Day 44-51))
Secondary Comparison of the sleep time and latency of sleep times before and after implementation of the recovery management program. Sleep time and latency of sleep are recorded by actimetry. 7 days (Day 15-Day 21)
Secondary Evaluation of the subjective perception of somnolence before and after implementation of the recovery management program. During the week of shift observation, before and after the working time, the subjective perception of somnolence is measured using the Karolinska scale (KSS ranging from 0 minimum to 9 maximum) to evaluate the impact of the recovery management program 6 days (each shift between Day 15- Day 21 & Day 44-51)
Secondary Evaluation of mental fatigue before and after implementation of the recovery management program During the week of shift observation, after work time, the mental fatigue is measured using a Visual Analogue Scale (VAS ranging from 0 minimum to 10 maximum) to evaluate the impact of the recovery management program. 6 days (each shift between Day 15- Day 21 & Day 44-51)
Secondary Evaluation of the overall sleepiness before and after implementation of the recovery management program After each monitored week of shift work, the overall sleepiness is measured using the Epworth Sleepiness Scale (ESS ranging from 0 minimum to 24 maximum) to evaluate the impact of the recovery management program 2 days (Day 22 & Day 51)
Secondary Evaluation of the sleep quality before and after implementation of the recovery management program After each monitored week of shift work, the overall sleep quality is measured using the Insomnia Severity Index (ISI ranging from 0 minimum to 28 maximum) to evaluate the impact of the recovery management program. 2 days (Day 22 & Day 51)
Secondary Evaluation of bedtime arousal before and after implementation of the recovery management program After each monitored week of shift work the sleep quality is measured using the score on the Pre-Sleep Arousal QScale (PSAS ranging from 16 minimum to 80 maximum) to evaluate the impact of the recovery management program. 2 days (Day 22 & Day 51)
Secondary Evaluation of the evolution of the perceived quality of sleep before and after implementation of the recovery management program. At the end of the study, the evolution of the perceived quality of sleep is measured using the Leeds questionnaire (LSEQ including VAS from 1 to 10) to evaluate the impact of the recovery management program. 1 day (Day 51)
Secondary Evaluation of the job satisfaction before and after implementation of the recovery management program Before and after implementation of the recovery, the job satisfaction is measured using a visual analogue scale for the effort-reward imbalance marker (ranging from 0 minimum to 10 maximum) to evaluate the impact of the recovery management program. 2 days (Day 22 & Day 51)
Secondary Evaluation of the reported adverse events before and after implementation of the recovery management program Before and after implementation of the recovery, the occurrence of adverse events is measured based on the records. Day 15- Day 21 & Day 44-51
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1